NAPROXEN
- Product NDC
- 43063-937
- 11-digit product format
- 430630937
- Labeler code
- 43063
- Product ID
- 43063-937_e6db06d9-9356-75ad-e053-2995a90a438f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NAPROXEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA091416
- Marketing category
- ANDA
- Marketing start
- 2016-07-06
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43063-937 | NAPROXEN TABLET [PD-RX PHARMACEUTICALS, INC.] | 11 | Legacy NDC | 20241018_270316dd-3869-4a24-ab8d-f1e69c59892c.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-937-20 | 43063093720 | 20 TABLET in 1 BOTTLE, PLASTIC (43063-937-20) | 20 tablet | 2019-02-14 | 0000-00-00 | No | No | Current |